Search for a trial

Multi-center, randomized, comparator-controlled, single-blind, parallel-group study to
investigate the pharmacodynamics, pharmacokinetics and safety of an intrauterine
system releasing BAY 1007626, as compared with Mirena and Jaydess, in a combined
proof-of-concept and dose-finding study in healthy pre-menopausal women treated for
90 days

The primary objective of this study is to investigate local and systemic effects of BAY 1007626 on:- Number of bleeding and spotting days,- Endometrial histology,- Ovulation (as surrogate for systemic effects).The secondary objective of this study…